Dataset from Effect of Antithymocyte Globulin on Preserving Beta Cell Function in New Onset Type 1 Diabetes Mellitus
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00008031
下载链接
链接失效反馈官方服务：
资源简介：
Antithymocyte globulin (e.g., Thymoglobulin®) is an antibody preparation that is commonly
used to treat and prevent organ transplant rejection. The START trial aims to determine
whether antithymocyte globulin (ATG) treatment can halt the progression of newly diagnosed
type 1 diabetes when given within 12 weeks of disease diagnosis.
创建时间：
2026-02-06
